CYTORI THERAPEUTICS, INC DEF 14A 8-28-2013

Company

PLUS THERAPEUTICS, INC.

Filed

July 19, 2013

Period of Report

August 28, 2013

Accession Number

0001095981-13-000014

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →